APA aipamena

Almuhtaseb, H., Kanavati, S., Rufai, S. R., & Lotery, A. J. (2017). One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration. Eye (Lond).

Chicago Style aipamena

Almuhtaseb, H., S. Kanavati, S R. Rufai, and A J. Lotery. "One-year Real-world Outcomes in Patients Receiving Fixed-dosing Aflibercept for Neovascular Age-related Macular Degeneration." Eye (Lond) 2017.

MLA aipamena

Almuhtaseb, H., S. Kanavati, S R. Rufai, and A J. Lotery. "One-year Real-world Outcomes in Patients Receiving Fixed-dosing Aflibercept for Neovascular Age-related Macular Degeneration." Eye (Lond) 2017.